MedKoo Cat#: 124044 | Name: ZY19489

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ZY19489 is an antimalarial agent.

Chemical Structure

ZY19489
ZY19489
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 124044

Name: ZY19489

CAS#: N/A

Chemical Formula: C24H32FN9

Exact Mass: 465.2800

Molecular Weight: 465.58

Elemental Analysis: C, 61.91; H, 6.93; F, 4.08; N, 27.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
MMV253; ZY19489; MMV-253; VL8W9427Y4; ZY-19489
IUPAC/Chemical Name
2-N-(4-cyclopropyl-5-fluoro-6-methylpyridin-2-yl)-5-[(3R)-3,4-dimethylpiperazin-1-yl]-4-N-(1,5-dimethylpyrazol-3-yl)pyrimidine-2,4-diamine
InChi Key
HKPQFVAUXAZCDY-OAHLLOKOSA-N
InChi Code
InChI=1S/C24H32FN9/c1-14-10-21(31-33(14)5)28-23-19(34-9-8-32(4)15(2)13-34)12-26-24(30-23)29-20-11-18(17-6-7-17)22(25)16(3)27-20/h10-12,15,17H,6-9,13H2,1-5H3,(H2,26,27,28,29,30,31)/t15-/m1/s1
SMILES Code
CC1=CC(NC2=NC(NC3=NC(C)=C(F)C(C4CC4)=C3)=NC=C2N5C[C@@H](C)N(C)CC5)=NN1C
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 465.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ghoghari AM, Patel HV, Nayak NN, Mansuri TH, Pillai SM, Jain MR, Patel HB, Kansagra K, Resta ID, Möhrle J, Parmar DV. Simultaneous estimation of ZY-19489 and its active metabolite ZY-20486 in human plasma using LC-MS/MS, a novel antimalarial compound. Bioanalysis. 2021 Dec;13(23):1761-1777. doi: 10.4155/bio-2021-0194. Epub 2021 Nov 15. PMID: 34779650. 2: Radohery GFR, Gower J, Barber BE, Kansagra K, Möhrle JJ, Davenport MP, McCarthy JS, Khoury DS, Rebelo M. Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study. Lancet Infect Dis. 2022 Jun;22(6):760-761. doi: 10.1016/S1473-3099(22)00294-8. PMID: 35643094. 3: Barber BE, Fernandez M, Patel HB, Barcelo C, Woolley SD, Patel H, Llewellyn S, Abd-Rahman AN, Sharma S, Jain M, Ghoghari A, Di Resta I, Fuchs A, Deni I, Yeo T, Mok S, Fidock DA, Chalon S, Möhrle JJ, Parmar D, McCarthy JS, Kansagra K. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study. Lancet Infect Dis. 2022 Jun;22(6):879-890. doi: 10.1016/S1473-3099(21)00679-4. Epub 2022 Mar 2. PMID: 35247321.